CAW
EW icon

Cornerstone Advisors (Washington)’s Edwards Lifesciences EW Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,325
Closed -$328K – 1019
2019
Q2 		$328K Buy
5,325
+147
+3% +$8.89K 0.03% 89
2019
Q1 		$330K Buy
5,178
+2,577
+99% +$147K 0.03% 82
2018
Q4 		$133K Buy
2,601
+123
+5% +$6.22K 0.02% 160
2018
Q3 		$144K Buy
2,478
+363
+17% +$17.8K 0.09% 161
2018
Q2 		$103K Buy
2,115
+111
+6% +$5.18K 0.07% 193
2018
Q1 		$93K Hold
2,004
– – 0.06% 201
2017
Q4 		$75K Sell
2,004
-576
-22% -$21.1K 0.05% 221
2017
Q3 		$94K Sell
2,580
-696
-21% -$26.5K 0.06% 195
2017
Q2 		$129K Buy
3,276
+657
+25% +$24K 0.07% 153
2017
Q1 		$82K Hold
2,619
– – 0.04% 205
2016
Q4 		$82K Sell
2,619
-606
-19% -$19.6K 0.07% 197
2016
Q3 		$130K Buy
3,225
+723
+29% +$27.2K 0.11% 133
2016
Q2 		$83K Sell
2,502
-6
-0.2% -$205 0.08% 119
2016
Q1 		$74K Buy
2,508
+162
+7% +$4.47K 0.08% 132
2015
Q4 		$62K Buy
2,346
+2,190
+1,404% +$56.9K 0.07% 154
2015
Q3 		$4K Hold
156
– – ﹤0.01% 581
2015
Q2 		$4K Hold
156
– – ﹤0.01% 440
2015
Q1 		$4K Hold
156
– – ﹤0.01% 460
2014
Q4 		$3K Hold
156
– – ﹤0.01% 489
2014
Q3 		$3K Sell
156
-24
-13% -$379 ﹤0.01% 329
2014
Q2 		$3K Hold
180
– – ﹤0.01% 364
2014
Q1 		$2K Buy
180
+24
+15% +$277 ﹤0.01% 367
2013
Q4 		$2K Hold
156
– – ﹤0.01% 236
2013
Q3 		$2K Hold
156
– – ﹤0.01% 217
2013
Q2 		$2K Buy
+156
New +$1.85K ﹤0.01% 180

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cornerstone Advisors (Washington)'s EW Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Edwards Lifesciences (EW) in Q3 2019, closing a stake of 5,325 shares — an estimated $328K sold.

Cornerstone Advisors (Washington) first reported a position in EW in Q2 2013 and held it in 25 quarters. The position peaked at $330K in Q1 2019. 965 funds tracked by Wall St. Rank hold EW as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Edwards Lifesciences position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 5,325 Edwards Lifesciences shares in Q3 2019, an estimated $328K.
  • Cornerstone Advisors (Washington) first reported a position in Edwards Lifesciences in Q2 2013 and held it in 25 quarters.
  • Cornerstone Advisors (Washington)'s Edwards Lifesciences position peaked at $330K in Q1 2019.
  • 965 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.